Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-29

Clinical Trial Update: Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating susceptibility testing of antimalarial drugs to improve management of drug-resistant malaria in Sub-Saharan Africa; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Bamenda | Conditions: Drug Resistant Malaria Due to Plasmodium Falciparum | Phase 3 | Status: COMPLETED